Cardiol Therapeutics Inc. — Investor Relations & Filings
Cardiol Therapeutics Inc. is a clinical-stage life sciences company dedicated to the research and clinical development of disease-modifying therapies for heart disease. The company focuses on developing anti-inflammatory and anti-fibrotic treatments designed to target the underlying mechanisms contributing to cardiac conditions. Its therapeutic pipeline, currently in clinical trials, addresses underserved heart diseases, including rare cardiac conditions such as Pericarditis and Myocarditis, as well as Heart Failure (Heart Failure with preserved ejection fraction (HFpEF) and Heart Failure with reduced ejection fraction (HFrEF)). The company leverages international research collaborations to advance its novel therapeutic approaches.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| News release - English.pdf | 2026-05-14 | English | |
| 52-109F2 - Certification of interim filings - CFO (E).pdf | 2026-05-11 | English | |
| Interim MD&A - English.pdf | 2026-05-11 | English | |
| Interim financial statements/report – English.pdf | 2026-05-11 | English | |
| News release - English.pdf | 2026-05-07 | English | |
| News release - English.pdf | 2026-04-28 | English |
Browse filings by year
10 yearsMarket data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
1NKEMIA
Biotechnology company providing R&D and services for the li…
|
IKM | ES | Professional, scientific and te… |
|
2cureX AB
Develops an IVD test using 3D tumoroids to predict patient …
|
2CUREX | SE | Professional, scientific and te… |
|
Abattis Bioceuticals Corp.
Life sciences company aggregating and investing in cannabis…
|
ATTBF | CA | Professional, scientific and te… |
|
Abera Bioscience AB
Develops mucosal vaccines using a proprietary Outer Membran…
|
ABERA | SE | Professional, scientific and te… |
|
ABION Inc.
Clinical-stage biopharma developing therapeutics for oncolo…
|
203400 | KR | Professional, scientific and te… |
|
ABL Bio Inc.
Develops bispecific antibody therapeutics for oncology and …
|
298380 | KR | Professional, scientific and te… |
| ABLYNX | — | BE | Professional, scientific and te… |
|
Abnova Corporation
Global leader in high-throughput production of antibodies a…
|
4133 | TW | Professional, scientific and te… |
|
Abpro Holdings, Inc.
Clinical-stage biotech developing antibody therapeutics for…
|
ABP | US | Professional, scientific and te… |
|
Absci Corp
A generative AI drug creation company developing biologic m…
|
ABSI | US | Professional, scientific and te… |
Cardiol Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/47487/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=47487 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=47487 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=47487 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 47487}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cardiol Therapeutics Inc. (id: 47487)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.